Last Updated: September 25, 2026

Novitium Pharma Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for NOVITIUM PHARMA

NOVITIUM PHARMA has one hundred and seventeen approved drugs.

There are three US patents protecting NOVITIUM PHARMA drugs. There is one tentative approval on NOVITIUM PHARMA drugs.

Summary for Novitium Pharma

US Patents:	3
Tradenames:	102
Ingredients:	101
NDAs:	117
Patent Litigation for Novitium Pharma:	See patent lawsuits for Novitium Pharma

Drugs and US Patents for Novitium Pharma

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novitium Pharma	DEXAMETHASONE	dexamethasone	TABLET;ORAL	215604-004	Oct 5, 2023	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Novitium Pharma	SIROLIMUS	sirolimus	SOLUTION;ORAL	211040-001	Jan 28, 2019	AA	RX	No	No		⤷ Start Trial				⤷ Start Trial
Novitium Pharma	NAPROXEN	naproxen	SUSPENSION;ORAL	211910-001	Mar 10, 2021	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Novitium Pharma	PROCHLORPERAZINE MALEATE	prochlorperazine maleate	TABLET;ORAL	216202-002	Jun 13, 2022	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Novitium Pharma	CHLORZOXAZONE	chlorzoxazone	TABLET;ORAL	212253-001	Nov 27, 2019	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Novitium Pharma

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.